Subham Basu

Chief Business Officer at Navinci

Subham Basu is Chief Business Officer at Navinci; with a wealth of expertise spanning life sciences and biopharma, he previously served as Senior Director for Commercial Strategy for Immuno-oncology and Oncology at Abcam. His advisory roles include guiding pharmaceutical, diagnostic industries, and venture capital funds as Head of Strategy at Inflection Point Biomedical Advisors. Previously, he contributed to medical affairs and market access at AZ, Shire/Baxalta, Otsuka Pharmaceuticals, and Genzyme. With a Ph.D. in Molecular Pharmacology from Cornell and a BS in Neuroscience from UC Berkeley, he directed a cancer research laboratory at Barts Cancer Institute, focusing on signaling and cell biology.